Biopharmaceutical

#Biopharmaceutical #Drug candidates #Drug development #Drug discovery #Metabolomics

Using the power of plants in drug discovery

Viswa Colluru, PhD, founder and CEO of Enveda Biosciences talks to Lu Rahman about the company’s chemical search engine and its work harnessing the complexity of the natural world to tackle today’s biggest healthcare challenges.  LR: Describe what Enveda does and some of its current work / initiatives. VC: Enveda… Read More

#Exclusive Content #News #Opinion

#Biopharmaceutical #Biotechnology #Drug development #Drug discovery #Life sciences

Evotec collaborates with Bristol Myers Squibb to advance therapeutics

Evotec has launched beLAB2122, a US$20 million BRIDGE (Biomedical Research, Innovation & Development Generation Efficiency) collaboration with Bristol-Myers Squibb. beLAB2122 brings together academic institutions from the Rhine-Main-Neckar region of Germany with the goal of efficiently advancing first-in-class therapeutic options across all therapeutic areas and formats into investable drug discovery and… Read More

#News

#Biologics / Biotechnology #Biopharmaceutical #Drug development #Drug discovery #Life sciences

Investment helps establish animal alternative skin testing technology

A near-£1 million investment will help University of Dundee spinout company Ten Bio to commercialise the human skin culture system it developed to provide a viable alternative for many experiments currently performed on animals. The investment will enable the company to progress its mission to transform the testing of new… Read More

#News

#Biopharmaceutical #Drug development #Drug discovery #mRNA

Evotec and Takeda enter RNA targeting drug discovery alliance

Evotec has entered into a multi-RNA target alliance with Takeda Pharmaceutical with the goal to discover and develop RNA targeting small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches. Evotec and Takeda will jointly identify and develop small molecules targeting a range of… Read More

#News

#Biopharmaceutical #Covid-19 #Immunology / Virology & Vaccines #Sputnik

RDIF and Stelis Biopharma partner to vaccinate 100 million with Sputnik V

The Russian Direct Investment Fund (RDIF) and Stelis Biopharma, the biopharmaceutical division of Strides, a global pharmaceutical company headquartered in India, have partnered to produce and supply a minimum of 200 million doses of the Russian Sputnik V vaccine against COVID-19, sufficient to vaccinate 100 million people. Sputnik V is now approved for… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Biopharmaceutical #Covid-19 #Immunology / Virology & Vaccines

Medicago and GSK start Phase III trial of COVID-19 vaccine candidate

Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) have begun Phase III clinical testing of Medicago’s plant-derived COVID-19 vaccine candidate in combination with GSK’s pandemic adjuvant, as part of the ongoing Phase II/III study. Medicago received approval from Canadian and U.S. regulatory authorities to proceed with enrolment… Read More

#Covid-19 #News

#Biopharmaceutical #Events

Gilead Company, Kite, to share scientific advances in virtual meeting

Biopharmaceutical company Kite will share its latest scientific advances in cell therapy research at the 47th Virtual Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) on March 14-17, 2021. 11 abstracts will be presented which demonstrate Kite’s commitment to innovation in cell therapy for patients with… Read More

#News

#Biopharmaceutical #Covid-19 #Drug delivery #Immunology / Virology & Vaccines

Novartis and CureVac sign COVID-19 vaccine candidate agreement

Novaratis has signed an initial agreement to manufacture biopharmaceutical company CureVac’s COVID-19 vaccine candidate, CVnCoV. Following final agreement, Novartis plans to start manufacturing of the mRNA and bulk drug product in the second quarter of 2021. It is anticipated to produce up to 50 million doses by the end of… Read More

#News

#Biopharmaceutical #Bioproduction #Biotechnology #Clinical diagnostics #Life sciences

Advanced Biological Safety Cabinet launched

Thermo Fisher Scientific has launched the Thermo Scientific Herasafe 2025 BSC, for the safe sample handling needs of life science applications. It is a Class II Biological Safety Cabinet (BSC) designed to meet the sample and user protection requirements of bioprocessing, clinical diagnostic and biopharmaceutical laboratories. According to Thermo Fisher… Read More

#News

#AI / data analytics / healthtech / informatics #Biopharmaceutical #Laboratory data

IDBS and Scitara form lab technology partnership

IDBS, innovator in Biopharmaceutical Lifecycle Management (BPLM), and Scitara, laboratory IoT expert, have partnered to create a solution that aims to extend IDBS Polar BPLM’s laboratory data connectivity and instrument integration capabilities. This integrated solution augments the Polar workflow capabilities , says IDBS, by addressing the challenge of sharing and… Read More

#News

#Biopharmaceutical #Drug discovery #Ion channels

Metrion Biosciences and Sosei Heptares form strategic drug discovery collaboration

Metrion Biosciences, the specialist ion channel CRO and drug discovery company and Sosei Group, an international biopharmaceutical group, will apply Sosei Heptares’ structure-based drug design (SBDD) expertise and platform to ion channels for the first time through a new strategic collaboration. Ion channels are a class of integral membrane proteins… Read More

#News